Neuroprotective efficacy of N-t-butylhydroxylamine (NtBHA) in transient focal ischemia in rats |
Kim, Eun-Sun
(College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University)
Shin, Yusun (College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University) Kim, Eun-Hye (College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University) Kim, Donghyun (College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University) De Felice, Milena (Sheffield Institute for Translational Neuroscience, University of Sheffield) Majid, Arshad (College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University) Bae, Ok-Nam (College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University) |
1 | Lees KR, Barer D, Ford GA, Hacke W, Kostulas V, Sharma AK, Odergren T, Investigators S-N-(2003) Tolerability of NXY-059 at higher target concentrations in patients with acute stroke. Stroke 34:482-487. https://doi.org/10.1161/01.str.0000053032.14223.81 DOI |
2 | Atamna H, Paler-Martinez A, Ames BN (2000) N-t-butyl hydroxylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J Biol Chem 275:6741-6748. https://doi.org/10.1074/jbc. 275. 10.6741 DOI |
3 | Kim HJ, Shin SW, Oh CJ, Lee MH, Yang CH, Park JW (2005) N-t-Butyl hydroxylamine regulates heat shock-induced apoptosis in U937 cells. Redox Rep 10:287-293. https://doi.org/10.1179/135100005X83662 DOI |
4 | Atamna H, Robinson C, Ingersoll R, Elliott H, Ames BN (2001) N-t-Butyl hydroxylamine is an antioxidant that reverses agerelated changes in mitochondria in vivo and in vitro. FASEB J 15:2196-2204. https://doi.org/10.1096/fj.01-0134com DOI |
5 | Kim ES, Kim D, Nyberg S, Poma A, Cecchin D, Jain SA, Kim KA, Shin YJ, Kim EH, Kim M, Baek SH, Kim JK, Doeppner TR, Ali A, Redgrave J, Battaglia G, Majid A, Bae ON (2020) LRP-1 functionalized polymersomes enhance the efficacy of carnosine in experimental stroke. Sci Rep 10:699. https://doi.org/10.1038/s41598-020-57685-5 DOI |
6 | Baek SH, Noh AR, Kim KA, Akram M, Shin YJ, Kim ES, Yu SW, Majid A, Bae ON (2014) Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage. Stroke 45:2438-2443. https://doi.org/10.1161/STROKEAHA.114.005183 DOI |
7 | Kim D, Kim EH, Bae ON (2021) Comparative study of two isothiazolinone biocides, 1,2-benzisothiazolin-3-one (BIT) and 4,5-dichloro-2-n-octyl-isothiazolin-3-one (DCOIT), on barrier function and mitochondrial bioenergetics using murine brain endothelial cell line (bEND.3). J Toxicol Environ Health A 84:932-943. https://doi.org/10.1080/15287 394. 2021. 19557 86 DOI |
8 | Lee JH, Tak JK, Park KM, Park JW (2007) N-t-Butyl hydroxylamine regulates ionizing radiation-induced apoptosis in U937 cells. Biochimie 89:1509-1516. https://doi.org/10.1016/j.biochi.2007.07.010 DOI |
9 | Lee H, Park J, Park K (2022) Assessment of agonistic and antagonistic properties of humidifier disinfectants to the estrogenic and androgenic receptors by transactivation assay. Toxicol Res 38:99-109. https://doi.org/10.1007/s43188-021-00111-3 DOI |
10 | Kim D, Kim EH, Choi S, Lim KM, Tie L, Majid A, Bae ON (2021) A commonly used biocide 2-N-octyl-4-isothiazolin- 3-oneInduces blood-brain barrier dysfunction via cellular thiol modification and mitochondrial damage. Int J Mol Sci. https://doi.org/10.3390/ijms22052563 DOI |
11 | Jain S, Kim ES, Kim D, Burrows D, De Felice M, Kim M, Baek SH, Ali A, Redgrave J, Doeppner TR, Gardner I, Bae ON, Majid A (2020) Comparative cerebroprotective potential of d-and l-carnosine following ischemic stroke in mice. Int J Mol Sci. https://doi.org/10.3390/ijms21093053 DOI |
12 | Sydserff SG, Borelli AR, Green AR, Cross AJ (2002) Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br J Pharmacol 135:103-112. https://doi.org/10.1038/sj.bjp.0704449 DOI |
13 | Lees KR, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Ashwood T, Hardemark HG, Wasiewski W, Emeribe U, Zivin JA, Investigators SI (2006) Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial. Stroke 37:2970-2978. https://doi.org/10.1161/01.STR.0000249410.91473.44 DOI |
14 | Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG (2006) Ischemic NXYTTI NXY-059 for acute ischemic stroke. N Engl J Med 354:588-600. https://doi.org/10.1056/NEJMoa052980 DOI |
15 | Zhao Z, Zhang X, Zhao C, Choi J, Shi J, Song K, Turk J, Ma ZA (2010) Protection of pancreatic beta-cells by group VIA phospholipase A(2)-mediated repair of mitochondrial membrane peroxidation. Endocrinology 151:3038-3048. https://doi.org/10.1210/en.2010-0016 DOI |
16 | Wang M, Zhang Y, Feng L, Zheng J, Fan S, Liu J, Yang N, Liu Y, Zuo P (2017) Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia-reperfusion injury in rats by targeting multiple cellular processes. Neuropsychiatr Dis Treat 13:927-935. https://doi.org/10.2147/NDT.S129522 DOI |
17 | Muir KW, Lees KR, Ford I, Davis S, Intravenous Magnesium Efficacy in Stroke Study I (2004) Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 363:439-445. https://doi.org/10.1016/S0140-6736(04)15490-1 DOI |
18 | Bath PM, Gray LJ, Bath AJ, Buchan A, Miyata T, Green AR, Investigators NXYEM-aiIAwS (2009) Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. Br J Pharmacol 157:1157-1171. https://doi.org/10.1111/j.1476-5381.2009.00196.x DOI |
19 | Green AR, Ashwood T, Odergren T, Jackson DM (2003) Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059. Pharmacol Ther 100:195-214. https://doi.org/10.1016/j.pharmthera.2003.07.003 DOI |
20 | Slemmer JE, Shacka JJ, Sweeney MI, Weber JT (2008) Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem 15:404-414. https://doi.org/10.2174/092986708783497337 DOI |
21 | Lees KR, Sharma AK, Barer D, Ford GA, Kostulas V, Cheng YF, Odergren T (2001) Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke. Stroke 32:675-680. https://doi.org/10.1161/01.str.32.3.675 DOI |
22 | Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hardemark HG, Rodichok L, Saint I, Investigators II (2008) NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials. Stroke 39:1751-1758. https://doi.org/10.1161/STROKEAHA.107.503334 DOI |
23 | Hill MD (2007) Stroke: the dashed hopes of neuroprotection. Lancet Neurol 6:2-3. https://doi.org/10.1016/s1474-4422(06) 70658-5 DOI |
24 | Bharate SS (2021) Critical analysis of drug product recalls due to nitrosamine impurities. J Med Chem 64:2923-2936. https://d oi.org/10.1021/acs.jmedchem.0c02120 DOI |
25 | Bae ON, Majid A (2013) Role of histidine/histamine in carnosineinduced neuroprotection during ischemic brain damage. Brain Res 1527:246-254. https://doi.org/10.1016/j.brainres.2013.07.004 DOI |
26 | Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA (2008) Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 39:2824-2829. https://doi.org/10.1161/STROKEAHA.108.515957 DOI |
27 | Proctor PH, Tamborello LP (2007) SAINT-I worked, but the neuroprotectant is not NXY-059. Stroke 38:e109; author reply e110. https://doi.org/10.1161/STROKEAHA.107.489161 DOI |
28 | Kim EH, Kim ES, Shin D, Kim D, Choi S, Shin YJ, Kim KA, Noh D, Caglayan AB, Rajanikant GK, Majid A, Bae ON (2021) Carnosine protects against cerebral ischemic injury by inhibiting matrix-metalloproteinases. Int J Mol Sci. https://doi.org/10.3390/ijms22147495 DOI |
29 | Choi SM, Cho YS, Park G, Lee SK, Chun KS (2021) Celecoxib induces apoptosis through Akt inhibition in 5-fluorouracil-resistant gastric cancer cells. Toxicol Res 37:25-33. https://doi.org/10.1007/s43188-020-00044-3 DOI |
30 | Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S, Investigators AT, Investigators ET, Investigators Nr-PSG (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768-774. https://doi.org/10.1016/S0140-6736(04)15692-4 DOI |
31 | Schreibelt G, van Horssen J, van Rossum S, Dijkstra CD, Drukarch B, de Vries HE (2007) Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev 56:322-330. https://doi.org/10.1016/j.brainresrev.2007.07.005 DOI |
32 | Sugawara T, Chan PH (2003) Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid Redox Signal 5:597-607. https://doi.org/10.1089/152308603770310266 DOI |
33 | Chao X, Zhou J, Chen T, Liu W, Dong W, Qu Y, Jiang X, Ji X, Zhen H, Fei Z (2010) Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats. Brain Res 1363:206-211. https://doi.org/10.1016/j.brainres.2010.09.052 DOI |
34 | Yang S, Li W (2016) Targeting oxidative stress for the treatment of ischemic stroke: Upstream and downstream therapeutic strategies. Brain Circulation 2:153. https://doi.org/10.4103/2394-8108.195279 DOI |
35 | Saeed SA, Shad KF, Saleem T, Javed F, Khan MU (2007) Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Exp Brain Res 182:1-10. https://doi.org/10.1007/s00221-007-1050-9 DOI |
36 | Chamulitrat W, Jordan SJ, Mason RP, Saito K, Cutler RG (1993) Nitric oxide formation during light-induced decomposition of phenyl N-tert-butylnitrone. J Biol Chem 268:11520-11527. https://doi.org/10.1016/S0021-9258(19) 50231-9 DOI |
37 | Ma S, Yin H, Chen L, Liu H, Zhao M, Zhang X (2012) Neuroprotective effect of ginkgolide K against acute ischemic stroke on middle cerebral ischemia occlusion in rats. J Nat Med 66:25-31. https://doi.org/10.1007/s11418-011-0545-7 DOI |
38 | Abe K, Tonomura M, Ito M, Takai N, Imamoto N, Rokugawa T, Momosaki S, Fukumoto K, Morimoto K, Inoue O (2015) Imaging of reactive oxygen species in focal ischemic mouse brain using a radical trapping tracer [(3)H]hydromethidine. EJNMMI Res 5:115. https://doi.org/10.1186/s13550-015-0115-1 DOI |
39 | Terasaki Y, Liu Y, Hayakawa K, Pham LD, Lo EH, Ji X, Arai K (2014) Mechanisms of neurovascular dysfunction in acute ischemic brain. Curr Med Chem 21:2035-2042. https://doi.org/10.2174/0929867321666131228223400 DOI |
40 | Shen H, Yuan Y, Ding F, Hu N, Liu J, Gu X (2010) Achyranthes bidentata polypeptides confer neuroprotection through inhibition of reactive oxygen species production, Bax expression, and mitochondrial dysfunction induced by overstimulation of N-methyl- D-aspartate receptors. J Neurosci Res 88:669-676. https://doi.org/10.1002/jnr.22221 DOI |
41 | Margaill I, Plotkine M, Lerouet D (2005) Antioxidant strategies in the treatment of stroke. Free Radic Biol Med 39:429-443. https://doi.org/10.1016/j.freeradbiomed.2005.05.003 DOI |
42 | Yamato M, Egashira T, Utsumi H (2003) Application of in vivo ESR spectroscopy to measurement of cerebrovascular ROS generation in stroke. Free Radic Biol Med 35:1619-1631. https://doi.org/10.1016/j.freeradbio med.2003.09.013 DOI |